Tirzepatide showed a significant reduction in LFC and VAT and in ASAT volumes compared with insulin degludec in this subpopulation of patients with type 2 diabetes in the SURPASS-3 study (55)
In an AD mouse model, GLP-1RAs were demonstrated to reduce the levels of AD pathological markers, including oligomeric antibodies and antibody plaque load, reduce the activation of microglia, and improve memory behavior (35, 44, 45)
Increased energy expenditure: Some research suggests semaglutide may slightly boost metabolism, further aiding weight loss
"M-1 Abrams Tank"
If youre eating less or eating more, exercising or not exercising, your body has a thermostat where it always tries to return to that body set weight
The pharmacy provides dosing instructions in units on a U-100 insulin syringe